Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 109796, 7 pages
http://dx.doi.org/10.1155/2012/109796
Research Article

Genetic Association of NPY Gene Polymorphisms with Dampness-Phlegm Pattern in Korean Stroke Patients

Brain Disease Research Center, and Division of Standard Research, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea

Received 23 June 2011; Accepted 2 October 2011

Academic Editor: Jae Youl Cho

Copyright © 2012 Mi Mi Ko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Chen, P. C. W. Fung, and R. T. F. Cheung, “Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat,” Free Radical Biology and Medicine, vol. 32, no. 8, pp. 776–784, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Wallerstedt, S. Skrtic, A. -L. Eriksson, C. Ohlsson, and T. Hedner, “Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population,” Journal of Hypertension, vol. 22, no. 7, pp. 1277–1281, 2004. View at Publisher · View at Google Scholar
  3. J. G. Wettstein, B. Earley, and J. L. Junien, “Central nervous system pharmacology of neuropeptide Y,” Pharmacology and Therapeutics, vol. 65, no. 3, pp. 397–414, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Morley and J. F. Flood, “Neuropeptide Y and memory processing,” Annals of the New York Academy of Sciences, vol. 611, pp. 226–231, 1990. View at Google Scholar · View at Scopus
  5. M. Heilig, G. F. Koob, R. Ekman, and K. T. Britton, “Corticotropin-releasing factor and neuropeptide Y: role in emotional integration,” Trends in Neurosciences, vol. 17, no. 2, pp. 80–85, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Heilig, S. McLeod, M. Brot et al., “Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects,” Neuropsychopharmacology, vol. 8, no. 4, pp. 357–363, 1993. View at Google Scholar · View at Scopus
  7. X. Y. Hua, J. H. Boublik, M. A. Spicer, J. E. Rivier, M. R. Brown, and T. L. Yaksh, “The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship,” Journal of Pharmacology and Experimental Therapeutics, vol. 258, no. 1, pp. 243–248, 1991. View at Google Scholar · View at Scopus
  8. J. F. Flood and J. E. Morley, “Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation,” Peptides, vol. 10, no. 5, pp. 963–966, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. Beninger, B. A. Wirsching, K. Jhamandas, and R. J. Boegman, “Animal studies of brain acetylcholine and memory,” Archives of Gerontology and Geriatrics, vol. 8, no. 1, pp. 71–89, 1989. View at Google Scholar · View at Scopus
  10. U. I. Tuor, P. A. T. Kelly, L. Edvinsson, and J. McCulloch, “Neuropeptide Y and the cerebral circulation,” Journal of Cerebral Blood Flow and Metabolism, vol. 10, no. 5, pp. 591–601, 1990. View at Google Scholar · View at Scopus
  11. P. S. Widdowson and A. E. Halaris, “Increased levels of neuropeptide Y-immunoreactivity in rat brain limbic structures following antidepressant treatment,” Journal of Neurochemistry, vol. 52, p. S77, 1989. View at Google Scholar
  12. S. O. Frederiksen, R. Ekman, C. G. Gottfries, E. Widerlov, and S. Jonsson, “Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics,” Acta Psychiatrica Scandinavica, vol. 83, no. 4, pp. 273–277, 1991. View at Google Scholar · View at Scopus
  13. S. M. Stahl, Essential Psychopharmacology: Neuroscientific Basis and Clinical Applications, Cambridge University Press, Cambridge, UK, 2nd edition, 2000.
  14. B. Beck, “Neuropeptide Y in normal eating and in genetic and dietary-induced obesity,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 361, no. 1471, pp. 1159–1185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. L. E. Kuo, J. B. Kitlinska, J. U. Tilan et al., “Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome,” Nature Medicine, vol. 13, no. 7, pp. 803–811, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kos, A. L. Harte, S. James et al., “Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 5, pp. E1335–E1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yang, H. Guan, E. Arany, D. J. Hill, and X. Cao, “Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor,” FASEB Journal, vol. 22, no. 7, pp. 2452–2464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Lappalainen, H. R. Kranzler, R. Malison et al., “A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States,” Archives of General Psychiatry, vol. 59, no. 9, pp. 825–831, 2002. View at Google Scholar · View at Scopus
  19. M. D. Koehnke, S. Schick, U. Lutz et al., “Severity of alcohol withdrawal symptoms and the T1128c polymorphism of the neuropeptide Y gene,” Journal of Neural Transmission, vol. 109, no. 11, pp. 1423–1429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Zhu, L. Pollak, S. Mottagui-Tabar et al., “NPY leu7pro and alcohol dependence in Finnish and Swedish populations,” Alcoholism: Clinical and Experimental Research, vol. 27, no. 1, pp. 19–24, 2003. View at Google Scholar · View at Scopus
  21. U. Jaakkola, U. Pesonen, E. Vainio-Jylhä, M. Koulu, M. Pöllönen, and J. Kallio, “The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy,” Experimental and Clinical Endocrinology and Diabetes, vol. 114, no. 4, pp. 147–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. T. M. Van Rossum, H. Pijl, R. A. H. Adan, B. Hoebee, and J. C. Seidell, “Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults,” International Journal of Obesity, vol. 30, no. 10, pp. 1522–1528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Mangan, J. M. Williams, S. M. Lathe, D. Karolchik, and W. C. Lathe, “UCSC genome browser: deep support for molecular biomedical research,” Biotechnology Annual Review, vol. 14, pp. 63–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Karolchik, A. S. Hinrichs, and W. J. Kent, “The UCSC genome browser,” in Current Protocols in Bioinformatics, chapter 1, 2007. View at Google Scholar
  25. N. S. Kim, S. M. Oh, M. M. Ko, M. H. Cha, B. K. Kang, and O. S. Bang, “Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke,” Clinical Biochemistry, vol. 42, no. 16-17, pp. 1699–1704, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. T. Yu, N. N. Yu, S. S. Gao et al., “Neuropeptide Y polymorphisms and ischemic stroke in Chinese population,” Clinica Chimica Acta, vol. 411, no. 3-4, pp. 242–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. J. Kim, H. S. Bae, S. U. Park, S. K. Moon, J. M. Park, and W. S. Jung, “Clinical approach to the standardization of oriental medical diagnostic pattern identification in stroke patients,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 768492, 7 pages, 2011. View at Publisher · View at Google Scholar
  28. WHO, “WHO international standard terminologies on traditional medicine in the western pacific region,” in WHO Western Pacific Regional Office, 2007. View at Google Scholar
  29. H. Y. Go, Y. K. Kim, B. K. Kang et al., “Report on the Korean standard differentiation of the symptoms and signs for the stroke-2,” Korean Journal of Oriental Physiology & Pathology, vol. 20, pp. 1789–1791, 2006. View at Google Scholar
  30. I. K. Min, C. H. Kim, J. W. Hwang et al., “The relation of Dampness-Phlegm and metabolic syndrome in acute stroke patients,” Journal of Korean Oriental Medicine, vol. 30, no. 1, pp. 109–119, 2009. View at Google Scholar
  31. J. H. Lim, M. M. Ko, J. S. Lee, O. S. Bang, and M. H. Cha, “Genetic association of SNPs located at PON1 gene with Dampness and phelgm pattern identification among Korea stroke patients,” Korean Jourrnal of Oriental Internal Medicine, vol. 31, no. 4, pp. 752–762, 2010. View at Google Scholar
  32. T. Ouyang, J. N. Song, Y. Miao et al., “Study on relationship between polymorphism of apolipoprotein E gene and syndromes of phlegm and blood stasis in patients with coronary heart disease,” Journal of Chinese Integrative Medicine, vol. 3, no. 6, pp. 438–442, 2005. View at Google Scholar · View at Scopus
  33. S. An, E. Li, and X. Tong, “Study on relationship between estrogen receptor gene polymorphism and syndrome differentiation typing of female postmenopausal osteoporosis in Traditional Chinese medicine,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 20, no. 12, pp. 907–910, 2000. View at Google Scholar · View at Scopus
  34. S. Chen, F. Lv, J. Gao et al., “HLA class II polymorphisms associated with the physiologic characteristics defined by traditional Chinese medicine: linking modern genetics with an ancient medicine,” Journal of Alternative and Complementary Medicine, vol. 13, no. 2, pp. 231–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. P. W. Hedrick, “Gametic disequilibrium measures: proceed with caution,” Genetics, vol. 117, no. 2, pp. 331–341, 1987. View at Google Scholar · View at Scopus
  36. J. K. Kim, I. C. Seol, I. Lee, H. K. Jo, B. C. Yu, and S. M. Choi, “Report on the Korean standard differentiation of the symptoms and signs for the stroke-1,” Korean Journal of Oriental Physiology & Pathology, vol. 20, pp. 229–234, 2006. View at Google Scholar
  37. M. K. Karvonen, U. Pesonen, M. Koulu et al., “Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels,” Nature Medicine, vol. 4, no. 12, pp. 1434–1437, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Ding, B. Kull, Z. Liu et al., “Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function,” Regulatory Peptides, vol. 127, no. 1–3, pp. 45–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Koulu, S. Movafagh, J. Tuohimaa et al., “Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization,” Annals of Medicine, vol. 36, no. 3, pp. 232–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Ding, “Distribution of the NPY 1128C allele frequency in different populations,” Journal of Neural Transmission, vol. 110, no. 11, pp. 1199–1204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Nyström, P. Nilsson, A. G. Olsson, B. E. Karlberg, and K. P. Öhman, “A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome,” Blood Pressure, vol. 5, no. 6, pp. 349–353, 1996. View at Google Scholar · View at Scopus
  42. M. Itokawa, M. Arai, S. Kato et al., “Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans,” Neuroscience Letters, vol. 347, no. 3, pp. 202–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. P. R. Buckland, B. Hoogendoorn, C. A. Guy et al., “A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1690, no. 3, pp. 238–249, 2004. View at Publisher · View at Google Scholar · View at Scopus